Mice and genotyping
Inducible and astroglia-specific GluA1 and GluA4 double knockouts (dKO) were generated by crossbreeding mice carrying the floxed gria1 (8) and gria4 (9) genes with mice expressing the tamoxifen-sensitive Cre recombinase CreERT2 under the control of the murine GLAST promoter (7) . Mouse lines are listed in the MGI DATABASE: Gria1 tm2Rsp ; Gria4 x GLAST +/+ were used. The primer sequences for genotyping were: for GluA1 flox, 5'-CACTCACAGCAATGAAGCAG-GAC-3' and 5'-CTGCCTGGGTAAAGTGACTTGG-3'; for GluA4 flox, 5'-CACTATGTCTC-AGTTCTCTCAAG-3' and 5'-ACGATTGCAACTAAGTTCACAC-3'; and for GLASTCreERT2, 5'-GAGGCACTTGGCTAGGCTCTGAGGA-3' and 5'-GAGGAGATCCTGAC-CGATCAGTTGG-3' and 5'-GGTGTACGGTCAGTAAATTGGACAT-3'. Some of the mice carried also the ROSA26-floxed-STOP-EYFP reporter gene for Cre activity (22) (Strain name at Jackson Laboratory: B6.129X1-Gt(ROSA)26Sortm1(EYFP)Cos/J). For some morphological studies the Z/EG reporter line (23) was included (Strain name at Jackson Laboratory: B6.129(Cg)-Tg(CAG-Bgeo/GFP)21Lbe/J). Mice were maintained on the C57Bl6 background. Animal experiments were performed according to German, Dutch and European guidelines for Animal Experimentation.
Tamoxifen treatment
Tamoxifen was dissolved in corn oil to obtain a 10 mg/ml solution. For all experiments mice were i.p. injected with a tamoxifen dosage of 100 mg/kg body weight for 5 days on a daily basis, except for the morphological reporter studies mice received only 2 injections. Injections were performed at 2 weeks or 2-3 months of age. Experimental cohorts were always injected at the same time. Control animals received the vehicle oil (oil controls) or tamoxifen (tam controls) when Glast-CreERT2 was present or not, respectively. Experiments were performed at several time points after the injections and are indicated in the text.
Immunohistochemistry and histology
Mice were anesthetized (2,2,2-tribromoethanol (2 % v/v) and amyl alcohol (2 % w/v, 0.2 ml/ 10 g body weight)), perfused with artificial cerebrospinal fluid (ACSF containing the following (in mM): 124 NaCl, 3.0 KCl, 2.0 CaCl 2 , 2.0 MgSO 4 , 1.25 NaH 2 PO 4 , 23 NaHCO 3 , and 10 glucose), and subsequently with 4% paraformaldehyde (PFA) in 0.1 M sodium phosph buffer. Brains were isolated and kept in the same fixative for 8-12 h at 4°C. Cerebellar sections of 40 µm were cut sagittally with a vibratome. Sections were washed with PBS and treated with 0.3 % Triton X-100 and 5 % horse serum in PBS for 1 h at RT. ate Primary antibodies were incubated over night at 4°C in same solution. Dilutions were as follows: for GluA1 (1:600, rabbit, Chemicon AB1504), GluA4 (1:300, rabbit, Chemicon AB1508), Glast (1:2000, guinea pig, Chemicon), Calbindin (1:300, mouse, Sigma), GFP (1:800, goat, Rockland), S100ß (1:1000, rabbit, Swant; 1:500, rabbit, Abcam), VGlut1 (1:10000, guinea pig, Chemicon), and for Vlgut2 (1:300, guinea pig, Chemicon).
Of note, the GluA4 antibody (AB1508, Chemicon) is directed against the carboxy terminus and recognizes only the long chain isoform of the GluA4 subunit (GluA4L), which is predominantly expressed in Bergmann glia. Granule cells are not labeled because they express mainly the short GluA4 isoform (GluA4c ) (24, 25) .
Secondary antibodies to mouse, rabbit, guinea pig and goat conjugated to Alexa 488 (1:2000 Molecular Probes), Alexa 555 (1:2000 Molecular Probes), Cy2 (1:100 Dianova) and Cy3 (1:1000 Dianova) were incubated in 2 % horse serum for 2 h at RT. For nuclei labeling TO-PRO 3 (1:2000, Invitrogen) or DAPI (0.025 µg/ml final concentration) was added to the secondary antibody.
Confocal images were collected with a LSM 510 Meta microscope using a 20x/0.5 PlanNeofluar and 40x/1.2 water-immersion C-Apochromat objective. Excitation was performed at 488 nm, 543 nm and 633 nm, emission was detected for Alexa 488/Cy2, Alexa 555/Cy3 and TO-PRO3 at 500-530 nm band-pass, 560 nm long-pass and 650-710 nm band-pass filter sets, respectively. Z-stack images were taken at 0.5 -1 µm intervals. For quantification of average fluorescence intensities ImageJ (http://rsb.info.nih.gov/ij/) was used and data were grouped per animal and normalized to controls.
For paraffin sections:
Following perfusion and over night post-fixation brains were embedded in paraffin. 5 µm thick cerebellar sections were cut sagittally using a microtome. For haematoxylin and eosin (H&E) counterstaining, sections first were deparaffinized and rehydrated and then successively incubated for 3-5 min in 0.1 % haematoxylin (color blue; basic tissue compartments) and 0.1 % eosin (color red, acidic tissue compartments).
For immuno-labeling on paraffin sections, following deparaffinization and rehydration, sections were cooked for 10 min in boiling citrate buffer (0.01 M, pH 6.0) in a conventional microwave (650 W). After cooling down to RT sections were rinsed with Tris buffer (0.05 M, pH 7.6) containing 2 % fat free milk powder. Following 5 min incubation in 3 % H 2 O 2 to quench endogenous peroxidase activity and washing in Tris buffer, sections were incubated for 10 min with 20 % goat serum in PBS/BSA (1% w/v BSA). Sections were then treated with primary antibodies diluted in PBS/BSA (1% w/v BSA) over night at 4°C. Dilutions were as follow: for GFAP (1:200, mouse, Novocastra), Mac3 (1:400, rat, BD Pharmingen), and CD3 (1:150, rat, Serotec). Biotinylated secondary antibodies against mouse or rat were then incubated for 30 min at RT and chromogenic staining was completed using HRP-DAB detection.
For TUNEL staining, paraffin sections were treated with DeadEndTM Colorimetric TUNEL System kit, Promega, following the manufacturer's instructions.
Electrophysiology
Following anaesthesia and decapitation, the cerebellum was rapidly transferred into ice-cold ACSF containing in mM: 125 NaCl, 2.5 KCl, 25 NaHCO 3 , 1.25 NaH 2 PO 4 , 25 glucose, 2.5 MgCl 2 and 0.5 CaCl 2 ; a pH of 7.4 was ensured by continuous gassing with carbogen (95% O 2 /5% CO 2 ). Sagittal slices of the vermis (250 µm) were prepared via a Vibratome, kept for 1 h in the same solution at 30° C and then maintained at room temperature before starting the recordings.
Slices were fixed in a recording chamber and perfused with gassed ACSF containing in mM 125 NaCl, 2.5 KCl, 25 NaHCO 3 , 1.25 NaH 2 PO 4 , 25 glucose, 0.5 Na-lactate, 1 MgCl 2 and 2 CaCl 2 ; pH 7.4. Whole-cell patch clamp recordings were performed from somata of BG and Purkinje cells (PCs). Cells were visualized using a 40x water-immersion objective on a fixed stage upright microscope. Recordings were controlled by pClamp software with a digidata 1322A interface and a MultiClamp 700B amplifier. Patch pipettes, puff application pipettes and stimulation electrodes were pulled with a horizontal puller from borosilicate glass capillaries.
For whole cell patch-clamp recordings of BG patch pipettes were filled with following solution (in mM): K-gluconate 140, EGTA 0.5, Na-ATP 2, Hepes 10, MgCl 2 x 6 H 2 O 2. BG were voltage-clamped at -80 mV. A puff application pipette filled with 1 mM D-aspartate and 10 µM AMPA was placed 10-20 µm away from the recorded cell in the molecular layer. Focal puff application took place every minute for 10 ms with 0.5 bar and the resulting current was recorded.
For whole cell patch-clamp recordings of PC, patch pipettes were filled with a solution containing in mM: 140 Cs-methanesulfonate, 5 CsCl, 2 MgCl 2 , 0.5 EGTA, 2 Na-ATP, 0.5 Na-GTP; pH was adjusted to 7.3, whereas stimulation electrodes were filled with ACSF. The stimulation electrode was placed into the distal part of the molecular layer at a distance of about 200 µm from the recorded cell. Stimulation of parallel fibers (PF) was achieved by a 100 µs pulses given as paired pulses (100 V; interstimulus interval 80 ms) at a frequency of 0.1 Hz delivered by a pulse stimulator. PC were voltage-clamped at -70 mV and the series resistance (5-10 MΩ) was monitored before and after experiments by applying short voltage pulses (10 ms, -5 mV) and compensated to 90%. Only cells with stable series resistance (change <20%) were included in the analysis. Whole-cell currents were recorded at 20 kHz and filtered with a Bessel filter at 4 kHz. Paired-pulse ratio (PPR) was calculated as the ratio of the amplitude of the second evoked excitatory postsynaptic current (eEPSC) to that of the first. eEPSC amplitudes and PPR were averaged per minute and normalized. For induction of LTD high-frequency PF stimulation (50 Hz for 1 s) was given, while at the same time the recorded PC was depolarized to 0 mV to mimic the climbing fiber input.
Recordings of spontaneous, miniature excitatory postsynaptic currents (mEPSCs) of PC were performed on coronal cerebellar slices. Spontaneous glutamatergic currents were isolated by bath application of 500 nM TTX and 10 µM gabazine. In these experiments patch pipettes were filled with the following solution (in mM): 145 Cs-methanesulfonate, 2 MgCl 2 , 0.5 EGTA, 2 Na-ATP, 0.5 Na-GTP; pH was adjusted to 7.3. All data were analyzed offline with Clampfit 10.2. Data are presented as mean + SEM and n represented the number of cells.
Electron microscopy
Following anaesthesia, mice were perfused with ACSF containing in mM: 124 NaCl, 3.0 KCl, 2.0 CaCl2, 2.0 MgSO4, 1.25 NaH2PO4, 23 NaHCO3, and 10 glucose, and subsequently with a fixative solution containing 4 % formaldehyde, 0.5 % glutaraldehyde in phosphate buffer with 0.5 % NaCl. Brains were isolated and post fixed in the same fixative for 2d. 1 mm sagittal cerebellar sections of the vermis were dehydrated in a graded series of ethanol and embedded in Epon. All cerebellar samples were trimmed to focus only on lobe 5 of the cerebellar cortex. Ultrathin sections (50 nm) were cut using a ultramicrotome and stained with an aqueous solution of 4% uranyl acetate followed by lead citrate according to (26) . EM images from the upper third of the molecular layer were taken at 3150x and 8000x with a microscope and an on-axis 2k camera. Per genotype 3-5 animals were processed and 5-8 random images were taken. For analysis, the experimenter was blinded for all images that were studied. Parallel fiber synapses were counted using ImageJ and divided by the respective image area. The resulting synapse density was averaged per genotype. The area of BG processes was analyzed with the point-hit method (27) using ImageJ and a grid area of 2.49 µm 2 . BG processes were identified by their irregular shape and characteristic bundles of intermediate filaments in a comparatively clear cytoplasm (28) .
DNA, mRNA and protein isolation
In order to analyze the recombination kinetics of the floxed AMPAR subunits in more detail, we simultaneously isolated DNA, mRNA and protein from the same cerebellar homogenate of each animal and time point studied. Half of the cerebellum (~ 25 mg) was homogenized in 600 µl sucrose buffer containing in mM: 320 sucrose, 10 Tris (pH 7.4), 1 NaHCO 3 and 1 MgCl 2 and protease inhibitors using the Precellys Ceramic Kit 1.4 mm and the Precellys 24 homogenizer. After short centrifugation, 100 μl of the homogenate was mixed with 500 μl RLT plus buffer and DNA and mRNA were isolated following the manufacturer's instructions. The remaining homogenate was used for protein analyses and Western blotting.
Real time quantitative PCR
Using SYBR Green and a 7500 Fast Real-Time PCR System we quantified, for each time point after treatment start, the relative changes of genomic recombination (excision of the floxed alleles for each AMPAR subunit) and the relative loss of GluA1 and GluA4 mRNA resulting from successful recombination (see Fig. S12 for more details). Genomic DNA and mRNA were isolated from the same sample (see above).
For the qPCR on genomic DNA the following primers were used: rec Gria1 (5'-GTTCAGACAGGGACCCTCTCA-3', 5'-GCCTGCCTGGGTAAAGTGACT-3'); rec Gria4 (5'-CCCAGCCCTATTTTAGAGCTGC-3', 5'-CGCCCGGCTTGTTATTGAA-3'). For genomic input control we used an intron-exon stretch of Neuregulin 1 type III (5'-GTGTGC-GGAGAAGGAGAAAACT-3', 5'-AGGCACAGAGAGGAATTCATTTCTTA-3').
For cDNA synthesis 1 μg of RNA, random hexamer and oligo-dT nucleotides and the Superscript III kit were used. For mRNA expression analyses we used the following primers: for gria1 (5'-TCATGCAGCAAGGATGTGAC-3', 5'-CCATCCTTTCCACAGTCAGG-3'); for gria4 (5'-GGGATGGTAGGAGAGCTTGTGT-3', 5'-TGATTGTCAGAGGTGCAATGG-3'); for gria2 (5'-CCAATGGGATAAGTTCGCATA-3', 5'-GCACAGCTTGCAGTGTTGA-3'); for gria3 (5'-AGCCGTGTGATACGATGAAA-3', 5'-GCAAGGTTTACAGGCGTTCT-3'); for Slc1a3 (5'-GTCGCGGTGATAATGTGGTA-3' and 5'-AATCTTCCCTGCGATCAAGA-3').
As endogenous gene controls Atp5b and Actb were used: for Atp5b (5'-GGATCTGCTGGCCCCATAC-3', 5'-CTTTCCAACGCCAGCACCT-3'); for Actb (5'-CTTCCTCCCTGGAGAAGAGC-3', 5'-ATGCCACAGGATTCCATACC-3').
Of note, the primers for gria4 recognize both the short and long isoforms of GluA4 transcript (GluA4pan). Data normalization and analysis were performed with the 7500 Fast System Software and Excel.
Western blotting
Cerebellar protein lysates were prepared as mentioned above, using sucrose buffer with protease inhibitors and the Precellys 24 homogenizer. 20 µg protein lysate was size-separated on 10% SDS-polyacrylamide gels and blotted onto nitrocellulose membranes following instructions from BioRad. Membranes were blocked in 5% milk powder prepared in phosphate buffer for 1 h at RT. Primary antibodies [GluA1 (1:1000, rabbit, Chemicon AB1504), GluA4 (1:500, rabbit, Chemicon AB1508), GLAST (1:5000, guinea pig, Chemicon), α-Tubulin (1:6000, mouse, Sigma), GAPDH (1:2000, mouse, Stressgen)] were diluted in blocking buffer and incubated overnight at 4°C. Membranes were washed with 0.05% PBS-Tween and then incubated with a horseradish peroxidase-conjugated secondary antibody (diluted 1:5.000-10.000 in blocking buffer). Proteins were detected with an enhanced chemiluminescence kit according to the manufacturer's instructions. Exposure of ECL films was between 10 s and 15 min depending on signal intensity. Films were scanned at grey-scale (300 dpi resolution) using a regular image scanner. The densitometeric analysis of scanned ECL films was carried out using ImageJ. The peak intensity values for GluA1, GluA4 and GLAST calculated by the software were normalized to the peak intensity values of GAPDH and α-Tubulin.
Erasmus Ladder
Cerebellar motor performance in adult dKO mice was tested using the Erasmus Ladder that has been extensively described in (17) . Shortly, the Erasmus Ladder is a computerized device that enables to monitor in real time the stepping pattern and the amount of missteps of mice while crossing the ladder. The ladder is composed of 2 X 37 rungs, which may be raised or lowered individually. One trial was defined as a single ladder crossing from shelter to shelter and one session consisted of 72 trials. Each mouse was tested once per day, first in four or five training sessions and then in three or four challenge sessions. As mice traversed the ladder, the number of missteps per trial was recorded. A misstep was defined as any step on one of the descended half-rungs. The average number of missteps per trial in a given session was taken as a measure of motor performance. Motor performance was tested at different time points before or after the tamoxifen and control injections.
In the challenge sessions mice had to avoid an obstacle, a rising rung in the swing phase of their right paw which was accompanied by a tone. A custom written real-time software analyzed the stepping pattern online and enabled a prediction when and where the mouse was going to place its right forepaw. This ensured that all mice were presented with the obstacle perturbation at an appropriate time and place (i.e. specific half-rung) by raising the half-rung with 18 mm so as to create an obstacle of 12 mm above the stepping surface of the mice. 285 ms before obstacle presentation the mice were given a 90 dB, 15 kHz tone (lasting 285 ms). The pressurized air outlets provided a background noise of 80 dB, which prevented auditory startle reactions. The challenge session also consisted of 72 trials. If the stepping pattern of a mouse was not predicted reliably, there would be no challenge in the trial. Mice with less than 36 challenges in a session were excluded. During all experiments the experimenter was blind to the genotype and treatment of all mice studied. Data analysis, e.g. average missteps for each mouse, was also done blind (for more details, see www.neurasmus.com).
Eyelid Conditioning
The surgical procedures to prepare mice for eyelid conditioning were as follows. Mice were anesthetized with a mixture of isoflurane, nitrous oxide and oxygen. An incision of 15-20 mm in diameter in the scalp was made to place a pedestal on the skull. Before each session a small magnet was placed with Superglue on the left lower eyelid and a giant magnetoresistive (GMR) sensor chip was placed on the pedestal above the upper left eyelid. The eyelid movements of each individual mouse were calibrated by analyzing the range from optimal closure to complete aperture. Normally when the eyelid is closed, the optimal obtained distance between the magnet and the sensor is 2 mm. With this magnetic distance measurement technique (MDMT) we measured the exact positions of the mouse eyelid while moving freely in their home cage during eyeblink conditioning (www.neurasmus.com). The experimental procedure for the eyeblink conditioning in mice has been described earlier in (19) . Shortly, after surgery mice were allowed to recover for 2-4 days. Mice were first habituated for 2 days their home cage placed in an isolation chamber, with a background noise of 68 dB to control for the effects of interfering variables during the sessions, and were given randomly unpaired presentations of the CS and US. For the CS we used an auditory tone (5 kHz, 370 ms, 72 to 82 dB depending on small eyelid startle responses, rise/fall 25 ms) and for the US a mild eye-puff (20 ms) that elicited a reflexive blink without a complete head jerk; CS and US co-terminate. We subsequently subjected the mice to an acquisition period (5 or 6 days), in which sessions consisted of 8 blocks of 8 trials and at which every block consisted of 1 US-only trial, 6 paired trials, and 1 CS-only trial. This was followed by an extinction period (4 days) in which sessions consisted of randomly unpaired presentations of the CS and US. All these presentations were separated by a random interval in the range of 30 ± 10 to 120 ± 20 s (in trials and blocks respectively). In addition, sessions started with an adaptation period of 15 min in the chambers to minimize the influence of stress conditioning. Analyses of the conditioned eyelid responses were performed with custom made computer software using LabVIEW. Eyelid responses in paired trials were categorized into auditory startle response (latency to peak 5-50 ms), short-latency responses (latency to onset 50-70 ms and latency to peak ~115 ms) and cerebellar conditioned responses (latency to onset 50-350 ms and latency to peak 360 ms). For CS only trials we used the same values, except that the latency to peak amplitude of the CR was smaller than 400 ms instead of 360 ms.
Statistical Analysis
Inter-group comparisons were done by a Mann Whitney t test or by two-tailed Student t test. For multiple comparisons data were analyzed with one-way or two-way ANOVA with Bonferroni's post-test. The levels of significance were set as * p < 0.05; ** p < 0.01; *** p < 0.001. Data are represented as means ± SEM unless stated otherwise.
Supplementary Text
GluA1 and GluA4 expression in the cerebellum:
In this study we induced gene recombination of GluA1 and GluA4 starting either at 2 weeks or around 2-3 months of age by injection of tamoxifen. GluA1 and GluA4 expression was evaluated by immunodetection in cerebellar sections and by RT-PCR and Western blot analysis of cerebellar homogenates. Tamoxifen-induced deletion of both subunits in young and adult mice revealed that the majority of cerebellar GluA1/A4-type AMPA receptors was of Bergmann glial origin.
Of note, the AMPAR subunit GluA4 exists as a short GluA4c and as a long GluA4L splice isoform, and in the cerebellum GluA4c is primarily expressed by granule cells whereas GluA4L is largely restricted to Bergmann glia (24, 25) . The antibody used in this study to detect GluA4 is directed against the carboxy terminus of the long chain isoform GluA4L.
GluA1 and GluA4L immunolabeling in cerebellar sections (Fig. 1, Fig. S13 ) clearly showed a predominant fluorescent signal intensity in the molecular layer of the cerebellar cortex, which was almost completely lost after astroglia-specific gene deletion, indicating that GluA1 and GluA4L subunit expression occurred mainly in Bergmann glia. GluA1 and GluA4L were not detected in Purkinje cells or in granule cells, consistent with previous reports (29) (30) (31) .
Analysis of mRNA expression in cerebellar homogenates revealed that about 85 % and 50 % of GluA1 and GluA4 expression, respectively, were of astroglial origin in young (Fig. S1) and adult (Fig. S12) brains. Because the GluA4 mRNA analysis included both short and long isoforms (GluA4pan), we attribute the residual 50 % GluA4 mRNA expression in dKO mice to granule cells that express GluA4c (25) .
Although astrocytes constitute only a minor fraction of all cerebellar cells, we determined that they comprise about 70 % in young (fourth postnatal week) (Fig. S1 ) and more than 90 % in adults (3 months) (Fig. 3A) of total GluA1 and GluA4L protein expression. The age-dependant difference in residual protein expression may indicate a developmental down-regulation of AMPAR subunit expression in other cell types. For example, this has been described for oligodendrocyte lineage cells (32, 33) . Residual AMPAR subunit expression in dKO mice can also be assigned to interneurons or deep cerebellar nuclei (29, 30, 34) .
Fig. S1 Extent of AMPAR subunit deletion and reporter gene recombination in the cerebellum
Young mice (age P14) were injected for 5 days (red arrowheads) and cerebellar preparations were analyzed 10 to 14 days after the first injection. (A) Relative mRNA expression (normalized to control samples) of GluA1 (14.7 ± 1.4 %, n = 9 vs. n = 8, p < 0.0001) and GluA4pan (51.7 ± 2.2 %, n = 9 vs. n = 8, p < 0.0001) was markedly reduced by 85 % and 50 %, respectively, in dKO mice, whereas, GluA2 and GluA3 mRNA levels were not altered. (B) Western blot analysis of GluA1 (top) and GluA4L (bottom) revealed a 73.2 ± 7.5 % and 70.1 ± 6.7 % (n = 8 vs. n = 5, p = 0.0016) reduction in protein expression, respectively, in dKO mice. Tam and oil controls had identical protein expression. (C-H) Virtually all BG (labeled here with S100β, red) are targeted for recombination as demonstrated by the intense Cre-sensitive expression of the reporter signal EYFP (green, enhanced with anti-GFP labeling) throughout the ML. Scale bars 100 µm (C-E) and 20 µm (F-H). 
Fig. S6 Synapse density during cerebellar development in dKO mice
(A) PF-PC synapse density was quantified by counting synapses in randomly taken EM images from the upper third of the ML. 5-8 images per animal were evaluated blindedly. Mice were injected at P14 and processed 12 and 30 days post injection (dpi). At 12 dpi dKO mice revealed a reduction of 31.4 ± 9.7 % (p = 0.0185) in synapse density. At 30 dpi, dKO mice showed a tendency to an increased synapse density by 32.8 ± 18.8 % (p = 0.1317). (B) EM images of the upper third of the ML from control and dKO at 30 dpi. BG processes are false-colored pink and synapses are indicated with asterisks. Relative BG process area was reduced by 48.8 ± 18.9 % (p = 0.041) in dKO compared to controls. Scale bar 1 µm.
Fig. S7 No signs of inflammation or apoptosis in the cerebellar cortex of dKO mice
Immunostaining for GFAP (brown) in sagittal cerebellar sections revealed no difference between controls (A) and dKO mice (B). (C, D) Immunosignals for Mac3 (activated microglia) and (F, G) for CD3 (invading T cells) were absent in both controls and dKO mice. As positive controls for Mac3 (E) and CD3 (H, arrowheads) immunostainings cerebellar sections of 8 months old Cnp1-null mutants (35) were used; depicted is the cerebellar white matter. (I, J) TUNEL labeling in control and dKO revealed no apoptotic cells, which were easily detected in a positive control of a wildtype embryo at E14.5 (K, arrowheads). All sections were counterstained with hemalaun (blue) to reveal nuclei. Scale bars 100 µm applies for all images. 
Fig. S10 VGlut2 immunostained puncta (CF terminals) are not overtly changed
Climbing fiber (CF) terminals were assessed by labeling the vesicular glutamate transporter 2 (VGlut2) (14) . PCs are stained with calbindin. There were no overall differences in VGlut2 puncta distribution and density between controls and dKO mice. Scale bar 20 µm. 3 ± 8.6 % (GluA1) and 25.5 ± 9.8 % (GluA4L), p < 0.05, was detected at 7 d. An almost complete loss of GluA1 and GluA4L immunosignals (94.5 ± 8.7 % and 94 ± 5.9 %, respectively, p < 0.001) were achieved 21 d after first injection.
Fig. S14 Faster turnover of BG AMPAR subunits in young mice
Mice at the ages of 2 and 8 weeks were injected with the same dosage of tamoxifen for 5 d. Cerebellar slices were analyzed at distinct time points after the first injection. Analysis was performed on confocal stacks of the molecular layer and average fluorescent intensities of GluA1 (A) and GluA4L (B) were normalized to the respective age matched littermate controls. In young injected mice protein turnover was much faster compared to adult injected dKO mice. There were no significant differences in timing of CRs between the two groups. Graph indicates mean percentages of CR peak times (10 ms bin) for each group during training session 2 and 6. At the end of the training session 6, the majority of CR peak times are clustered around US onset in both groups. (CS onset is set at 0 ms, US onset at 350 ms and US duration is 30 ms).
